Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1266072.RA6vLj6Zgnuyy4BuMV-yucKZFnyORq8e3Y0FkrC0AKjxQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1266072.RA6vLj6Zgnuyy4BuMV-yucKZFnyORq8e3Y0FkrC0AKjxQ130_assertion type Assertion NP1266072.RA6vLj6Zgnuyy4BuMV-yucKZFnyORq8e3Y0FkrC0AKjxQ130_head.
- NP1266072.RA6vLj6Zgnuyy4BuMV-yucKZFnyORq8e3Y0FkrC0AKjxQ130_assertion description "[Bladder carcinomas, gallbladder, extrahepatic cholangiocarcinomas, cervical, uterine, and testicular cancers showed HER2 positivity rates of 12.4, 9.8, 6.3, 3.9, 3.0, and 2.4�%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1266072.RA6vLj6Zgnuyy4BuMV-yucKZFnyORq8e3Y0FkrC0AKjxQ130_provenance.
- NP1266072.RA6vLj6Zgnuyy4BuMV-yucKZFnyORq8e3Y0FkrC0AKjxQ130_assertion evidence source_evidence_literature NP1266072.RA6vLj6Zgnuyy4BuMV-yucKZFnyORq8e3Y0FkrC0AKjxQ130_provenance.
- NP1266072.RA6vLj6Zgnuyy4BuMV-yucKZFnyORq8e3Y0FkrC0AKjxQ130_assertion SIO_000772 25712293 NP1266072.RA6vLj6Zgnuyy4BuMV-yucKZFnyORq8e3Y0FkrC0AKjxQ130_provenance.
- NP1266072.RA6vLj6Zgnuyy4BuMV-yucKZFnyORq8e3Y0FkrC0AKjxQ130_assertion wasDerivedFrom befree-2016 NP1266072.RA6vLj6Zgnuyy4BuMV-yucKZFnyORq8e3Y0FkrC0AKjxQ130_provenance.
- NP1266072.RA6vLj6Zgnuyy4BuMV-yucKZFnyORq8e3Y0FkrC0AKjxQ130_assertion wasGeneratedBy ECO_0000203 NP1266072.RA6vLj6Zgnuyy4BuMV-yucKZFnyORq8e3Y0FkrC0AKjxQ130_provenance.